Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease. [electronic resource]
Publication details: Clinical kidney journal Feb 2019Description: 129-138 p. digitalISSN:- 2048-8505
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.